Literature DB >> 24418307

Socioeconomic status. The relationship with health and autoimmune diseases.

Omar-Javier Calixto1, Juan-Manuel Anaya2.   

Abstract

Socioeconomic status (SES) is a hierarchical social classification associated with different outcomes in health and disease. The most important factors influencing SES are income, educational level, occupational class, social class, and ancestry. These factors are closely related to each other as they present certain dependent interactions. Since there is a need to improve the understanding of the concept of SES and the ways it affects health and disease, we review herein the tools currently available to evaluate SES and its relationship with health and autoimmune diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Rheumatoid arthritis; Sjögren's syndrome; Socioeconomic status; Systemic lupus erythematosus; Systemic sclerosis; Type 1 diabetes

Mesh:

Year:  2014        PMID: 24418307     DOI: 10.1016/j.autrev.2013.12.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  42 in total

Review 1.  Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors:  Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

2.  The Social Gap Index and the prevalence of osteoarthritis in the community: a cross-sectional multilevel study in Mexico.

Authors:  Jacqueline Rodriguez-Amado; Jose Moreno-Montoya; Jose Alvarez-Nemegyei; Maria Victoria Goycochea-Robles; Luz Helena Sanin; Ruben Burgos-Vargas; Mario Humberto Cardiel; Mario Alberto Garza-Elizondo; Marco Maradiaga; Ingris Pelaez-Ballestas
Journal:  Clin Rheumatol       Date:  2014-09-18       Impact factor: 2.980

3.  Socioeconomic disparities of depressive symptoms and cytokines in hepatocellular carcinoma.

Authors:  Hoyee H Cheng; Thomas W Kamarck; Peter J Gianaros; Kathryn A Roecklein; Yanet Vanegas; Allan Tsung; David A Geller; James W Marsh; Nadia S Ahmed; Jennifer L Steel
Journal:  Psychooncology       Date:  2019-06-18       Impact factor: 3.894

4.  Racial or Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-specific Quality of Life.

Authors:  Heather Orom; Caitlin Biddle; Willie Underwood; Gregory G Homish; Carl A Olsson
Journal:  Urology       Date:  2017-08-24       Impact factor: 2.649

5.  The Roles of Socioeconomic Status, Occupational Health and Job Rank on the Epidemiology of Different Psychiatric Symptoms in a Sample of UK Workers.

Authors:  B Lopes; C Kamau; R Jaspal
Journal:  Community Ment Health J       Date:  2018-03-06

6.  Predictive value of anti-citrullinated peptide antibodies: a real life experience.

Authors:  Abdulla Watad; Nancy Agmon-Levin; Boris Gilburd; Merav Lidar; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

7.  Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.

Authors:  David H Chae; Connor D Martz; Thomas E Fuller-Rowell; Erica C Spears; Tianqi Tenchi Gao Smith; Evelyn A Hunter; Cristina Drenkard; S Sam Lim
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

8.  Socio-economic status and lifestyle factors are associated with achalasia risk: A population-based case-control study.

Authors:  Helen G Coleman; Ronan T Gray; Kar W Lau; Conall McCaughey; Peter V Coyle; Liam J Murray; Brian T Johnston
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 9.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

10.  Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.

Authors:  Peter Hollander; Klaus Rostgaard; Karin E Smedby; Ellen T Chang; Rose-Marie Amini; Peter de Nully Brown; Bengt Glimelius; Hans-Olov Adami; Mads Melbye; Ingrid Glimelius; Henrik Hjalgrim
Journal:  Am J Epidemiol       Date:  2015-09-06       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.